EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Major bioactive metabolites derived from Tripterygium wilfordii: structures, mechanisms, and therapeutic potentials

Yujie Jin, Jiahao Xu, Xiangyu Yan, Ruoting Tong, Zhanyan Zhang, Ye Ling, Yan Ma, Chenglin Huang, Qixia Zhan, Xiaojian Leng, Junjun He, Lizhuo Wang und 1 weitere

Frontiers in Pharmacology · 06.07.2026 · 17

DOI: 10.3389/fphar.2026.1664766 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.07.2026. Verfasst von Yujie Jin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Genetic Metabolism, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical C…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tripterygium wilfordii , a traditional Chinese botanical drug, has emerged as a rich source of bioactive metabolites with promising therapeutic potential. Among its metabolites, diterpenoids and triterpenoids—such as triptolide, triptonide, and celastrol—exhibit potent immunosuppressive, anti-inflammatory, and anti-tumor properties through modulation of key molecular pathways including NF-κB, JAK/STAT, and TGF-β/Smad. This review provides a comprehensive overview of the chemical classification, pharmacological mechanisms, and clinical translation of major metabolites derived from T. wilfordii. It highlights their application in autoimmune diseases, cancer, fibrosis, and metabolic disorders, while addressing current challenges in safety, solubility, and bioavailability. Advancements in drug delivery systems, structural modification, and precision medicine approaches are also discussed. Together, these insights aim to guide future research and translational development of T. wilfordii-based compoundic therapeutics.

Schlagwörter

Stichwörter der Autor:innen

Tripterygium wilfordiicelastrolditerpenoidspharmacological mechanismstoxicitytriptolide

Autor:innen und Institutionen

  • Department of Endocrinology and Genetic Metabolism, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
  • Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
  • Anhui Province Key Laboratory of Basic d Research an Transformation of Age-Related Diseases, Wannan Medical University, Wuhu, Anhui, China.
  • Department of Biochemistry and Molecular Biology, Wannan Medical University, Wuhu, Anhui, China.
  • Department of Endocrinology, Guangde People's Hospital, Guangde, Anhui, China.

Zitieren

APA

Jin, Y., Xu, J., Yan, X., Tong, R., Zhang, Z., Ling, Y., Ma, Y., Huang, C., Zhan, Q., Leng, X., He, J., Wang, L., & Gao, J. (2026). Major bioactive metabolites derived from Tripterygium wilfordii: structures, mechanisms, and therapeutic potentials. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1664766

Vancouver

Jin Y, Xu J, Yan X, Tong R, Zhang Z, Ling Y, et al. Major bioactive metabolites derived from Tripterygium wilfordii: structures, mechanisms, and therapeutic potentials. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1664766

BibTeX
@article{Jin2026,
  author = {Jin, Yujie and Xu, Jiahao and Yan, Xiangyu and Tong, Ruoting and Zhang, Zhanyan and Ling, Ye and Ma, Yan and Huang, Chenglin and Zhan, Qixia and Leng, Xiaojian and He, Junjun and Wang, Lizhuo and Gao, Jialin},
  title = {Major bioactive metabolites derived from Tripterygium wilfordii: structures, mechanisms, and therapeutic potentials},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1664766}
}
Kostenlos starten →